DNA Biomed (Israel) Price Prediction
| DNA Stock | ILS 103.00 18.00 21.18% |
Oversold Vs Overbought
57
Oversold | Overbought |
DNA Biomed Solns stock price prediction is an act of determining the future value of DNA Biomed shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of DNA Biomed's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of DNA Biomed and does not consider all of the tangible or intangible factors available from DNA Biomed's fundamental data. We analyze noise-free headlines and recent hype associated with DNA Biomed Solns, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of DNA Biomed based on different types of headlines from major news networks to social media. The DNA stock price prediction module provides an analysis of price elasticity to changes in media outlook on DNA Biomed over a specific investment horizon. Using DNA Biomed hype-based prediction, you can estimate the value of DNA Biomed Solns from the perspective of DNA Biomed response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in DNA Biomed. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in DNA Biomed to buy its stock at a price that has no basis in reality. In that case, they are not buying DNA because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
DNA Biomed after-hype prediction price | ILA 103.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
DNA |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DNA Biomed's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
DNA Biomed After-Hype Price Prediction Density Analysis
As far as predicting the price of DNA Biomed at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in DNA Biomed or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of DNA Biomed, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
DNA Biomed Estimiated After-Hype Price Volatility
In the context of predicting DNA Biomed's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on DNA Biomed's historical news coverage. DNA Biomed's after-hype downside and upside margins for the prediction period are 98.64 and 107.36, respectively. We have considered DNA Biomed's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
DNA Biomed is very steady at this time. Analysis and calculation of next after-hype price of DNA Biomed Solns is based on 3 months time horizon.
DNA Biomed Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as DNA Biomed is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DNA Biomed backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with DNA Biomed, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.85 | 4.36 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
103.00 | 103.00 | 0.00 |
|
DNA Biomed Hype Timeline
DNA Biomed Solns is currently traded for 103.00on Tel Aviv Stock Exchange of Israel. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. DNA is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.85%. %. The volatility of related hype on DNA Biomed is about 0.0%, with the expected price after the next announcement by competition of 103.00. About 55.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.95. Some equities with similar Price to Book (P/B) outperform the market in the long run. DNA Biomed Solns had not issued any dividends in recent years. The entity had 1:6 split on the 10th of November 2019. Assuming the 90 days trading horizon the next forecasted press release will be in a few days. Check out DNA Biomed Basic Forecasting Models to cross-verify your projections.DNA Biomed Related Hype Analysis
Having access to credible news sources related to DNA Biomed's direct competition is more important than ever and may enhance your ability to predict DNA Biomed's future price movements. Getting to know how DNA Biomed's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how DNA Biomed may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TEVA | Teva Pharmaceutical Industries | 0.00 | 0 per month | 1.49 | 0.18 | 3.46 | (3.33) | 8.70 | |
| ESLT | Elbit Systems | 0.00 | 0 per month | 0.00 | (0.1) | 1.72 | (2.31) | 6.69 | |
| BEZQ | Bezeq Israeli Telecommunication | 0.00 | 0 per month | 0.00 | (0.16) | 2.15 | (1.69) | 5.75 | |
| ICL | ICL Israel Chemicals | 0.00 | 0 per month | 0.00 | (0.05) | 3.65 | (3.51) | 9.32 |
DNA Biomed Additional Predictive Modules
Most predictive techniques to examine DNA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for DNA using various technical indicators. When you analyze DNA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About DNA Biomed Predictive Indicators
The successful prediction of DNA Biomed stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as DNA Biomed Solns, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of DNA Biomed based on analysis of DNA Biomed hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to DNA Biomed's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to DNA Biomed's related companies. Story Coverage note for DNA Biomed
The number of cover stories for DNA Biomed depends on current market conditions and DNA Biomed's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that DNA Biomed is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about DNA Biomed's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
DNA Biomed Short Properties
DNA Biomed's future price predictability will typically decrease when DNA Biomed's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of DNA Biomed Solns often depends not only on the future outlook of the potential DNA Biomed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. DNA Biomed's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 99.7 M |
Check out DNA Biomed Basic Forecasting Models to cross-verify your projections. Note that the DNA Biomed Solns information on this page should be used as a complementary analysis to other DNA Biomed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for DNA Stock analysis
When running DNA Biomed's price analysis, check to measure DNA Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Biomed is operating at the current time. Most of DNA Biomed's value examination focuses on studying past and present price action to predict the probability of DNA Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Biomed's price. Additionally, you may evaluate how the addition of DNA Biomed to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |